{"product_id":"nsj-v3652-100ug","title":"Recombinant CD43 Antibody, 100 ug","description":"\u003cp\u003eIt recognizes a cell surface glycoprotein of 95\/115\/135kDa (depending upon the extent of glycosylation), identified as CD43. 70-90% of T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be a malignant lymphoma, especially a low-grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma.\u003c\/p\u003e","brand":"NSJ Bioreagents","offers":[{"title":"100 ug","offer_id":51548858548504,"sku":"V3652-100UG","price":559.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/files\/get_image_3b97c8c8-7e0b-4096-97a6-f83e669dd2b2.jpg?v=1768288023","url":"https:\/\/danabiosci.com\/products\/nsj-v3652-100ug","provider":"Dana Bioscience","version":"1.0","type":"link"}